{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:38:39Z","timestamp":1792535919202,"version":"4.5.0"},"reference-count":105,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,8,24]]},"DOI":"10.1001\/jama.2021.10403","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:18:14Z","timestamp":1629803894000},"page":"744","source":"Crossref","is-referenced-by-count":87,"title":["Screening for Prediabetes and Type 2 Diabetes"],"prefix":"10.1001","volume":"326","author":[{"given":"Daniel E.","family":"Jonas","sequence":"first","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Department of Internal Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Crotty","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"RTI International, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D. Y.","family":"Yun","sequence":"additional","affiliation":[{"name":"Thayer Internal Medicine, MaineGeneral Health, Waterville, Maine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Cook","family":"Middleton","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Feltner","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"},{"name":"Department of Medicine, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Taylor-Phillips","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick, Coventry, West Midlands, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Barclay","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Department of Internal Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dotson","sequence":"additional","affiliation":[{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Baker","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey P.","family":"Balio","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane E.","family":"Voisin","sequence":"additional","affiliation":[{"name":"RTI International\u2013University of North Carolina at Chapel Hill Evidence-based Practice Center, Chapel Hill"},{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Harris","sequence":"additional","affiliation":[{"name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill"},{"name":"Department of Medicine, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"14","key":"jus210014r2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.2018.0158","article-title":"The state of US Health, 1990-2016: burden of diseases, injuries, and risk factors among US states.","volume":"319","author":"Mokdad","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"jus210014r3","first-page":"1","article-title":"Deaths: leading causes for 2017.","volume":"68","author":"Heron","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"jus210014r5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"jus210014r6","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020.","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"jus210014r11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"jus210014r12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"jus210014r13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"64","key":"jus210014r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20640","article-title":"A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.","volume":"20","author":"Simmons","year":"2016","journal-title":"Health Technol Assess"},{"key":"jus210014r16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ypmed.2015.12.012","article-title":"A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let\u2019s Prevent Diabetes cluster randomised controlled trial.","volume":"84","author":"Davies","year":"2016","journal-title":"Prev Med"},{"issue":"8","key":"jus210014r17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007316","article-title":"Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial.","volume":"5","author":"Sakane","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"jus210014r18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S2213-8587(13)70204-3","article-title":"Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial.","volume":"2","author":"Bhopal","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"jus210014r19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00592-017-1015-9","article-title":"Effect of lifestyle improvement program on the biomarkers of adiposity, inflammation and gut hormones in overweight\/obese Asian Indians with prediabetes.","volume":"54","author":"Gokulakrishnan","year":"2017","journal-title":"Acta Diabetol"},{"issue":"4","key":"jus210014r20","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14040417","article-title":"One-year results of a synthetic intervention model for the primary prevention of T2D among elderly individuals with prediabetes in rural China.","volume":"14","author":"Hu","year":"2017","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"jus210014r21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.amepre.2017.01.008","article-title":"PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin.","volume":"52","author":"O\u2019Brien","year":"2017","journal-title":"Am J Prev Med"},{"issue":"10077","key":"jus210014r22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 Years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"jus210014r23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/dom.12877","article-title":"Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.","volume":"19","author":"Currie","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"5-6","key":"jus210014r24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11357-016-9946-6","article-title":"Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.","volume":"38","author":"Espinoza","year":"2016","journal-title":"Age (Dordr)"},{"issue":"10","key":"jus210014r25","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial.","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"jus210014r26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002078","article-title":"Engagement, retention, and progression to type 2 diabetes: a retrospective analysis of the cluster-randomised \u201cLet\u2019s Prevent Diabetes\u201d trial.","volume":"13","author":"Gray","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"jus210014r27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ijo.2016.35","article-title":"Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA trial.","volume":"40","author":"Welsh","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"jus210014r28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2337\/dc15-1899","article-title":"Effective translation of an intensive lifestyle intervention for Hispanic women with prediabetes in a community health center setting.","volume":"39","author":"Van Name","year":"2016","journal-title":"Diabetes Care"},{"issue":"11","key":"jus210014r29","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2105\/AJPH.2015.302641","article-title":"A randomized comparative effectiveness trial for preventing type 2 diabetes.","volume":"105","author":"Ackermann","year":"2015","journal-title":"Am J Public Health"},{"issue":"11","key":"jus210014r30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"jus210014r31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pcd.2015.07.002","article-title":"Effectiveness of a brief theory-based health promotion intervention among adults at high risk of type 2 diabetes: one-year results from a randomised trial in a community setting.","volume":"10","author":"Juul","year":"2016","journal-title":"Prim Care Diabetes"},{"issue":"11","key":"jus210014r32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/dom.2015.17.issue-11","article-title":"Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.","volume":"17","author":"Kaku","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"jus210014r33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1403494814528290","article-title":"Feasibility of a randomized controlled intervention with physical activity in participants with impaired glucose tolerance recruited by FINDRISC: a pilot study.","volume":"42","author":"Hellgren","year":"2014","journal-title":"Scand J Public Health"},{"issue":"6","key":"jus210014r34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"jus210014r35","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.4897","article-title":"Diabetes prevention and weight loss with a fully automated behavioral intervention by email, web, and mobile phone: a randomized controlled trial among persons with prediabetes.","volume":"17","author":"Block","year":"2015","journal-title":"J Med Internet Res"},{"issue":"2","key":"jus210014r36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1370\/afm.1737","article-title":"Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.","volume":"13","author":"Echouffo-Tcheugui","year":"2015","journal-title":"Ann Fam Med"},{"issue":"4","key":"jus210014r37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13410-014-0191-1","article-title":"Saxagliptin as initial therapy in treatment-naive Indian adults with type 2 diabetes mellitus inadequately controlled with diet and exercise alone: a randomized, double-blind, placebo-controlled, phase IIIb clinical study.","volume":"34","author":"Kumar","year":"2014","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"2","key":"jus210014r38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00125-010-1949-8","article-title":"Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.","volume":"54","author":"Simmons","year":"2011","journal-title":"Diabetologia"},{"key":"jus210014r39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/1471-2458-8-350","article-title":"Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.","volume":"8","author":"Park","year":"2008","journal-title":"BMC Public Health"},{"issue":"5","key":"jus210014r40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005656","article-title":"Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study\u2014secondary analysis of the randomized trial.","volume":"4","author":"Uusitupa","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"jus210014r41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12325-011-0022-4","article-title":"Outcome of intensive integrated intervention in participants with impaired glucose regulation in China.","volume":"28","author":"Lu","year":"2011","journal-title":"Adv Ther"},{"issue":"6","key":"jus210014r42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00125-009-1315-x","article-title":"Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).","volume":"52","author":"Ramachandran","year":"2009","journal-title":"Diabetologia"},{"issue":"7","key":"jus210014r43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2337\/dc08-2141","article-title":"Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes.","volume":"32","author":"Kulzer","year":"2009","journal-title":"Diabetes Care"},{"issue":"9","key":"jus210014r44","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1111\/jgs.2012.60.issue-9","article-title":"Enhanced fitness: a randomized controlled trial of the effects of home-based physical activity counseling on glycemic control in older adults with prediabetes mellitus.","volume":"60","author":"Morey","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"jus210014r45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0168-8227(00)00244-8","article-title":"Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months.","volume":"52","author":"Oldroyd","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"jus210014r46","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2337\/dc09-0130","article-title":"Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial.","volume":"32","author":"Yates","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"jus210014r47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.","volume":"67","author":"Kosaka","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"jus210014r48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study.","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"issue":"9855","key":"jus210014r49","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(12)61422-6","article-title":"Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.","volume":"380","author":"Simmons","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"jus210014r50","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00125-011-2441-9","article-title":"How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? twelve year follow-up of the Ely cohort.","volume":"55","author":"Rahman","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"jus210014r51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/dme.2012.29.issue-7","article-title":"Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.","volume":"29","author":"Rahman","year":"2012","journal-title":"Diabet Med"},{"issue":"pt 1","key":"jus210014r52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1348\/135910710X495366","article-title":"Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.","volume":"16","author":"Paddison","year":"2011","journal-title":"Br J Health Psychol"},{"issue":"7618","key":"jus210014r53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/bmj.39303.723449.55","article-title":"Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.","volume":"335","author":"Eborall","year":"2007","journal-title":"BMJ"},{"issue":"7642","key":"jus210014r54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/bmj.39474.922025.BE","article-title":"Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.","volume":"336","author":"Davies","year":"2008","journal-title":"BMJ"},{"key":"jus210014r55","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2333","article-title":"Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care.","volume":"344","author":"Khunti","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"jus210014r56","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance.","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"jus210014r57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.","volume":"31","author":"Dagenais","year":"2008","journal-title":"Diabetes Care"},{"issue":"15","key":"jus210014r58","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes.","volume":"355","author":"Bosch","year":"2006","journal-title":"N Engl J Med"},{"issue":"9541","key":"jus210014r59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"issue":"18","key":"jus210014r60","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"jus210014r61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"issue":"4","key":"jus210014r62","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"issue":"12","key":"jus210014r63","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s11606-012-2122-5","article-title":"Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.","volume":"27","author":"Florez","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"9675","key":"jus210014r64","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.","volume":"373","author":"Kawamori","year":"2009","journal-title":"Lancet"},{"issue":"9626","key":"jus210014r65","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"issue":"16","key":"jus210014r66","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa1001122","article-title":"Effect of nateglinide on the incidence of diabetes and cardiovascular events.","volume":"362","author":"Holman","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"jus210014r67","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events.","volume":"362","author":"McMurray","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"jus210014r68","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/dmrr.v24:8","article-title":"A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI).","volume":"24","author":"Nijpels","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"15","key":"jus210014r69","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/archinternmed.2011.275","article-title":"Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial.","volume":"171","author":"Saito","year":"2011","journal-title":"Arch Intern Med"},{"issue":"9735","key":"jus210014r70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(10)60746-5","article-title":"Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.","volume":"376","author":"Zinman","year":"2010","journal-title":"Lancet"},{"issue":"9323","key":"jus210014r71","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"jus210014r72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"jus210014r73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"jus210014r74","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dc11-1299","article-title":"Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","journal-title":"Diabetes Care"},{"issue":"9786","key":"jus210014r75","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"jus210014r76","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1111\/dme.2012.29.issue-11","article-title":"Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? findings from the ADDITION-Europe cluster-randomized trial.","volume":"29","author":"Simmons","year":"2012","journal-title":"Diabet Med"},{"issue":"11","key":"jus210014r77","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00125-013-3011-0","article-title":"Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial.","volume":"56","author":"Van den Donk","year":"2013","journal-title":"Diabetologia"},{"issue":"10","key":"jus210014r78","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study.","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"jus210014r79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11136-010-9604-x","article-title":"No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients: the ADDITION-Netherlands study.","volume":"19","author":"van den Donk","year":"2010","journal-title":"Qual Life Res"},{"issue":"558","key":"jus210014r80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3399\/bjgp09X394851","article-title":"Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION-Netherlands study.","volume":"59","author":"Janssen","year":"2009","journal-title":"Br J Gen Pract"},{"issue":"7160","key":"jus210014r81","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"issue":"15","key":"jus210014r82","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"jus210014r83","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","article-title":"Long-term follow-up after tight control of blood pressure in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"9131","key":"jus210014r84","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"jus210014r85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/dom.2011.13.issue-2","article-title":"Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? the Nepi ANtidiabetes StudY (NANSY).","volume":"13","author":"Lindblad","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"jus210014r86","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2458-9-342","article-title":"Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.","volume":"9","author":"Penn","year":"2009","journal-title":"BMC Public Health"},{"issue":"1","key":"jus210014r87","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2458-11-40","article-title":"Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.","volume":"11","author":"Sakane","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"jus210014r88","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1403494808101373","article-title":"A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-term impact but long-term adherence problems.","volume":"37","author":"Lindahl","year":"2009","journal-title":"Scand J Public Health"},{"issue":"4","key":"jus210014r89","doi-asserted-by":"publisher","first-page":"S324","DOI":"10.1016\/j.amepre.2012.12.015","article-title":"The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.","volume":"44","author":"Katula","year":"2013","journal-title":"Am J Prev Med"},{"issue":"3","key":"jus210014r90","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0168-8227(03)00117-7","article-title":"Efficacy of acarbose in Chinese subjects with impaired glucose tolerance.","volume":"61","author":"Pan","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"jus210014r91","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7326\/M18-1605","article-title":"Long-term weight loss with metformin or lifestyle intervention in the Diabetes Prevention Program Outcomes Study.","volume":"170","author":"Apolzan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"9702","key":"jus210014r92","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"jus210014r93","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2337\/dc12-0227","article-title":"Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese.","volume":"36","author":"Yang","year":"2013","journal-title":"Diabetes Care"},{"issue":"9131","key":"jus210014r94","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"jus210014r95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2337\/dc18-1970","article-title":"Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.","volume":"42","author":"Diabetes Prevention Program Research Group","year":"2019","journal-title":"Diabetes Care"},{"key":"jus210014r96","doi-asserted-by":"crossref","DOI":"10.1177\/2150132719847374","article-title":"Evaluation of a community-based diabetes prevention program in Thailand: a cluster randomized controlled trial.","volume":"10","author":"Aekplakorn","year":"2019","journal-title":"J Prim Care Community Health"},{"issue":"10","key":"jus210014r97","first-page":"1343","article-title":"Effects of a health promotion program conducted by nurses on stabilization of HBA1C in subjects at risk for diabetes: a phase III randomized controlled trial.","volume":"101","author":"Moungngern","year":"2018","journal-title":"J Med Assoc Thailand"},{"issue":"6","key":"jus210014r98","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"jus210014r99","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/ijmr.IJMR_455_17","article-title":"Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: a pilot randomized control trial.","volume":"148","author":"Kulkarni","year":"2018","journal-title":"Indian J Med Res"},{"issue":"3","key":"jus210014r100","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.dsx.2017.09.011","article-title":"The 24-month metabolic benefits of the healthy living partnerships to prevent diabetes: a community-based translational study.","volume":"12","author":"Pedley","year":"2018","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"jus210014r101","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s13104-018-3810-y","article-title":"Five-year effectiveness of short messaging service (SMS) for pre-diabetes.","volume":"11","author":"Wong","year":"2018","journal-title":"BMC Res Notes"},{"issue":"3","key":"jus210014r102","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diabres.2013.10.002","article-title":"A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial.","volume":"102","author":"Wong","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"jus210014r103","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S2213-8587(19)30349-3","article-title":"Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.","volume":"7","author":"Griffin","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"jus210014r104","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/(ISSN)1520-7560","article-title":"Diabetes risk score: towards earlier detection of type 2 diabetes in general practice.","volume":"16","author":"Griffin","year":"2000","journal-title":"Diabetes Metab Res Rev"},{"issue":"19","key":"jus210014r105","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"jus210014r4","volume-title":"National Diabetes Day Fact Sheet, 2011","year":"2011"},{"key":"jus210014r8","volume-title":"Screening for Prediabetes and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 207","author":"Jonas","year":"2021"},{"key":"jus210014r9","volume-title":"Human Development Report 2016: Human Development for Everyone.","author":"Jahan","year":"2016"},{"key":"jus210014r10","volume-title":"Comparative Effectiveness Review Methods: Clinical Heterogeneity","author":"West","year":"2010"},{"key":"jus210014r14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions.","author":"Higgins","year":"2011"},{"key":"jus210014r1","unstructured":"National diabetes statistics report, 2020. Centers for Disease Control and Prevention. Published 2021. Accessed April 17, 2021. https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf"},{"key":"jus210014r7","unstructured":"Procedure Manual. US Preventive Services Task Force. Published 2015. Accessed July 13, 2021. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/procedure-manual"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2783415\/jama_jonas_2021_us_210014_1629733302.09334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:18:47Z","timestamp":1629803927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2783415"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,24]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.10403","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}